nutrients-logo

Journal Browser

Journal Browser

Age-Related Macular Degeneration: Advances in Diet and Nutrition Management

A special issue of Nutrients (ISSN 2072-6643). This special issue belongs to the section "Clinical Nutrition".

Deadline for manuscript submissions: closed (25 November 2022) | Viewed by 7463

Special Issue Editors


E-Mail Website
Guest Editor
Bordeaux Population Health Research Center (INSERM U1219), Université de Bordeaux, Bordeaux, France
Interests: age-related macular degeneration; nutrition; ocular diseases; epidemiology; cohort study; nutritional biomarkers

E-Mail Website
Guest Editor
Bordeaux Population Health Research Center (INSERM U1219), Université de Bordeaux, Bordeaux, France
Interests: age-related diseases; aging; eye diseases; physical performance; diabetes; AMD

Special Issue Information

Dear Colleagues,

Age-related eye diseases are a major global health issue, since more than 20% of the elderly (>80 years old) are diagnosed with AMD. The role of nutrition in ocular aging is attracting growing interest, with hypotheses focusing on the joint effect of antioxidants and lipids. Epidemiological studies have identified several foods and nutrients of interest as well as dietary patterns related to AMD, but many nutritional exposures remain unexplored. Over the past 15 years, we have accumulated a lot of knowledge about the beneficial effects of a healthy diet for AMD prevention. The next step is to evaluate this knowledge and disseminate it to the general population, patients, and practitioners (doctors, pharmacists, nutritionists). The management of nutritional aspects in the prevention of AMD has been improved. You are invited to submit proposals for manuscripts that fit the objectives and the topics of this Special Issue

Dr. Bénédicte M.J. Merle
Dr. Cécile Delcourt
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nutrients is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • AMD
  • age-related eye diseases
  • aging
  • nutrition
  • bioactive foods
  • biomarkers
  • diet intervention

Published Papers (3 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Other

15 pages, 570 KiB  
Article
Serum 25-Hydroxyvitamin D Is Differentially Associated with Early and Late Age-Related Macular Degeneration in the United States Population
by Yihang Fu, Xiaoyun Chen, Sheng Luo, Shuangyan Jiang, Yuxiang Mao and Wei Xiao
Nutrients 2023, 15(5), 1216; https://doi.org/10.3390/nu15051216 - 28 Feb 2023
Viewed by 1747
Abstract
Background: Age-related macular degeneration (AMD) has been the leading cause of irreversible blindness in industrialized countries. Emerging data suggest that serum vitamin D levels may be associated with AMD but show mixed results. National-level population data on the relationship between vitamin D and [...] Read more.
Background: Age-related macular degeneration (AMD) has been the leading cause of irreversible blindness in industrialized countries. Emerging data suggest that serum vitamin D levels may be associated with AMD but show mixed results. National-level population data on the relationship between vitamin D and AMD severities are still lacking. Methods: We used data from the National Health and Nutrition Examination Survey (NHANES) 2005 to 2008. Retinal photographs were taken and graded for AMD stage. The odds ratio (OR) of AMD and its subtype was calculated after adjusting for confounding factors. Restricted cubic spline (RCS) analyses were used to explore potential non-linear relations. Results: A total of 5041 participants with a mean age of 59.6 years were included. After adjusting for covariates, participants with higher level of serum 25-hydroxyvitamin D [25(OH)D] had significantly greater odds of early AMD (OR, 1.65; 95% CI, 1.08–2.51) and decreased risk of late AMD (OR, 0.29; 95% CI, 0.09–0.88). When stratified by age, a positive association between the level of serum 25(OH)D and early AMD was present in the <60 years group (OR, 2.79; 95% CI, 1.08–7.29), whereas a negative relation between the level of serum 25(OH)D and late AMD was detected in the ≥60 years group (OR, 0.24; 95% CI, 0.08–0.76). Conclusions: A higher level of serum 25(OH)D was related to increased risk of early AMD in those <60 years and decreased risk of late AMD in those ≥60 years. Full article
Show Figures

Figure 1

12 pages, 457 KiB  
Article
B Vitamins and Incidence of Advanced Age-Related Macular Degeneration: The Alienor Study
by Bénédicte M. J. Merle, Stéphanie Barthes, Catherine Féart, Audrey Cougnard-Grégoire, Jean-François Korobelnik, Marie-Bénédicte Rougier, Marie-Noëlle Delyfer and Cécile Delcourt
Nutrients 2022, 14(14), 2821; https://doi.org/10.3390/nu14142821 - 8 Jul 2022
Cited by 8 | Viewed by 2461
Abstract
B vitamins may protect against age-related macular degeneration (AMD). We evaluated the associations of dietary intake and serum vitamins with the incidence of advanced AMD in the Alienor study. The Alienor study is a prospective population-based cohort of 963 residents of Bordeaux, France, [...] Read more.
B vitamins may protect against age-related macular degeneration (AMD). We evaluated the associations of dietary intake and serum vitamins with the incidence of advanced AMD in the Alienor study. The Alienor study is a prospective population-based cohort of 963 residents of Bordeaux, France, who were 73 years or older at baseline (2006–2008). Examinations were performed every two years over an eight-year period. The incidence of AMD is based on retinal fundus photographs and spectral-domain optical coherence tomography examinations. Among the 861 included participants, 93 developed incident AMD during a median follow-up time of 9.8 years. Participants with normal serum folate (≥10 nmol/L) significantly had a 51% reduced risk for AMD in the fully adjusted Cox model (HR, 0.49 [95% CI, 0.25–0.95], p = 0.036). Participants with a higher dietary intake of B5 and B6 vitamins had a lower risk for developing AMD of up to 28% (HR, 0.72 for 1-SD increase [0.53–0.99], p = 0.049; HR, 0.90 [0.81–0.99], p = 0.049, respectively). This cohort study of older adults suggests a strong association between a normal serum folate status, a high dietary intake of B5 and B6 and a lower risk for developing advanced AMD. Adopting a healthy diet rich in B vitamins may help to reduce vision loss due to AMD. Full article
Show Figures

Figure 1

Other

Jump to: Research

20 pages, 990 KiB  
Systematic Review
What Advice Is Currently Given to Patients with Age-Related Macular Degeneration (AMD) by Eyecare Practitioners, and How Effective Is It at Bringing about a Change in Lifestyle? A Systematic Review
by Sonali Dave, Alison Binns, Valldeflors Vinuela-Navarro and Tamsin Callaghan
Nutrients 2022, 14(21), 4652; https://doi.org/10.3390/nu14214652 - 3 Nov 2022
Cited by 4 | Viewed by 2664
Abstract
There is currently no treatment for early/intermediate Age-related Macular Degeneration (AMD) but Eye Care Professionals (ECPs) are recommended to advise patients about modifiable lifestyle factors, including dietary changes, that can slow disease progression. The aim of this review was to understand advice currently [...] Read more.
There is currently no treatment for early/intermediate Age-related Macular Degeneration (AMD) but Eye Care Professionals (ECPs) are recommended to advise patients about modifiable lifestyle factors, including dietary changes, that can slow disease progression. The aim of this review was to understand advice currently given to patients with AMD by ECPs and to evaluate evidence regarding patient compliance. A systematic review was conducted of literature published in electronic databases: CINAHL, MEDLINE, PsycINFO, PyscARTICLES, EMBASE, AMED. Methods followed PRISMA guidelines (PROSPERO registration number: CRD42020223724). Twenty-four reports were eligible for inclusion, 12 focused on ECP experience, 7 on patient experience, and 6 on impact of advice (one paper reported on the ECP and patient experience). Studies reported that a substantial proportion of patients did not recall receiving lifestyle modification advice from their ECP (57.95%, range 2–95% across patient based studies). Practitioners were most likely to provide advice about nutritional supplements (80%, range 67–93% across ECP studies), and least likely about smoking (44%, range 28–71% across ECP studies), however supplements advised did not always comply with evidence-based guidelines. The main reason for patients not following lifestyle advice was lack of provision by the ECP (54.5%, range 21–94% across studies on the impact of advice). The review highlighted a need for more studies to understand patient preferences for receiving advice and research on ECP perceived barriers to advice provision. Full article
Show Figures

Figure 1

Back to TopTop